PTHS vs UNH · rev $16.8M vs P/E 30, rev $112.03B
Pelthos Therapeutics Inc. (PTHS) versus UnitedHealth Group Incorporated (UNH) — a side-by-side from cached financials, not a winner call.
Pelthos Therapeutics Inc. (PTHS) is a biotechnology company listed on AMEX.
UnitedHealth Group Incorporated (UNH) is a healthcare plans company listed on NYSE. It is led by Stephen J. Hemsley.
Latest reported PTHS revenue for 2025-12-31 was $16.8M. Net income was -$43.3M. PTHS currently screens at market cap $94.7M.
Latest reported UNH revenue for 2026-06-30 was $112.03B. Net income was $5.48B. Revenue was up 0.3% from 2026-03-31 to 2026-06-30. UNH currently screens at market cap $362.83B and trailing P/E 30.1.
PTHS currently screens at market cap $94.7M. UNH currently screens at market cap $362.83B and trailing P/E 30.1.
Not investment advice. Open the PTHS and UNH stock pages for the full models.
Not investment advice.